Heska Corporation To Present At The LD MICRO Sixth Annual Conference

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

LOVELAND, Colo., Nov. 13, 2013 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and other specialty veterinary products, today announced that Robert Grieve, the Company's Chairman and Chief Executive Officer, is to present at the LD MICRO Sixth Annual Conference at 8:30 a.m. (PST), Track 3, on December 4, 2013. The conference will be held at the Luxe Sunset Bel Air, 11461 Sunset Boulevard, Los Angeles, California. Interested parties may contact LD MICRO at 408-457-1042 or eric@ldmicro.com for registration information.

The Company's group presentation is to be available for the public to access via its corporate website at www.heska.com. This webcast is to be available via Heska's website for two weeks following the live presentation.

About LD MICRO
LD MICRO is a by-invitation only newsletter firm that focuses on finding undervalued companies in the micro-cap space. Since 2002, the firm has published an annual list of recommended stocks as well as comprehensive reports on select companies throughout the year. LD MICRO concentrates on finding, researching, and investing in companies that are overlooked by institutional investors.

About Heska
Heska Corporation (NASDAQ: HSKA - News) sells advanced veterinary diagnostic and other specialty veterinary products. Heska's state-of-the-art offerings to its customers include diagnostic instruments and supplies as well as single-use, point-of-care tests, pharmaceuticals and vaccines. The Company's core focus is on the canine and feline markets where it strives to provide high value products and unparalleled customer support to veterinarians. For further information on Heska and its products, visit the company's website at www.heska.com.

SOURCE Heska Corporation



Help employers find you! Check out all the jobs and post your resume.

Back to news